SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
The Scripps Research Institute and Aileron Therapeutics Enter Exclusive Worldwide Agreement to Utilize "Click" Chemistry for the Development of Stabilized Peptide and Protein Therapeutics